Hepatic glucagon action: beyond glucose mobilization

被引:5
|
作者
Kajani, Sarina [1 ]
Laker, Rhianna C. [1 ]
Ratkova, Ekaterina [2 ]
Will, Sarah [1 ]
Rhodes, Christopher J. [1 ]
机构
[1] AstraZeneca, Early Cardiovasc, Renal & Metab, Biopharmaceut R&D, Gaithersburg, MD 20878 USA
[2] AstraZeneca, Early Cardiovasc, Renal & Metab, Biopharmaceut R&D, Molndal, Sweden
关键词
glucagon; glucose production; lipogenesis; liver; metabolism; ACTIVATED PROTEIN-KINASE; ACETYL-COA CARBOXYLASE; FATTY-ACID OXIDATION; NECROLYTIC MIGRATORY ERYTHEMA; HORMONE-SENSITIVE LIPASE; CREB COACTIVATOR TORC2; ALPHA CELL HYPERPLASIA; UREA-CYCLE ENZYMES; AMINO-ACID; RAT HEPATOCYTES;
D O I
10.1152/physrev.00028.2023
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Glucagon's ability to promote hepatic glucose production has been known for over a century, with initial observations touting this hormone as a diabetogenic agent. However, glucagon receptor agonism [when balanced with an incretin, including glucagon-like peptide 1 (GLP-1) to dampen glucose excursions] is now being developed as a promising therapeutic target in the treatment of metabolic diseases, like metabolic dysfunction-associated steatotic disease/metabolic dysfunction-associated steatohepatitis (MASLD/MASH), and may also have benefit for obesity and chronic kidney disease. Conventionally regarded as the opposing tag-team partner of the anabolic mediator insulin, glucagon is gradually emerging as more than just a "catabolic hormone." Glucagon action on glucose homeostasis within the liver has been well characterized. However, growing evidence, in part thanks to new and sensitive "omics" technologies, has implicated glucagon as more than just a "glucose liberator." Elucidation of glucagon's capacity to increase fatty acid oxidation while attenuating endogenous lipid synthesis speaks to the dichotomous nature of the hormone. Furthermore, glucagon action is not limited to just glucose homeostasis and lipid metabolism, as traditionally reported. Glucagon plays key regulatory roles in hepatic amino acid and ketone body metabolism, as well as mitochondrial turnover and function, indicating broader glucagon signaling consequences for metabolic homeostasis mediated by the liver. Here we examine the broadening role of glucagon signaling within the hepatocyte and question the current dogma, to appreciate glucagon as more than just that "catabolic hormone."
引用
收藏
页码:1021 / 1060
页数:41
相关论文
共 50 条
  • [31] Glucagon's yin and yang effects on hepatic glucose production
    Edgerton, Dale S.
    Cherrington, Alan D.
    NATURE MEDICINE, 2013, 19 (06) : 674 - 675
  • [32] GLUCAGON AND THE EXERCISE-INDUCED RISE IN HEPATIC GLUCOSE OUTPUT
    BJORKMAN, O
    FELIG, P
    WAHREN, J
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1980, 10 (02) : 3 - 3
  • [33] ACUTE REGULATION OF HEPATIC PROTEIN PHOSPHATASES BY GLUCAGON, INSULIN, AND GLUCOSE
    TOTH, B
    BOLLEN, M
    STALMANS, W
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1988, 263 (28) : 14061 - 14066
  • [34] THE EFFECT OF TOLBUTAMIDE ON HEPATIC EXTRACTION OF INSULIN AND GLUCAGON AND HEPATIC GLUCOSE OUTPUT IN ANESTHETIZED DOGS
    ISHIDA, T
    CHOU, MCY
    LEWIS, RM
    HARTLEY, CJ
    ENTMAN, M
    FIELD, JB
    ENDOCRINOLOGY, 1981, 109 (02) : 443 - 450
  • [35] Glucagon Deficiency Reduces Hepatic Glucose Production and Improves Glucose Tolerance In Adult Mice
    Hancock, Aidan S.
    Du, Aiping
    Liu, Jingxuan
    Miller, Mayumi
    May, Catherine L.
    MOLECULAR ENDOCRINOLOGY, 2010, 24 (08) : 1605 - 1614
  • [36] REGULATION OF HEPATIC REGENERATION IN RATS BY SYNERGISTIC ACTION OF INSULIN AND GLUCAGON
    BUCHER, NLR
    SWAFFIELD, MN
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (03) : 1157 - 1160
  • [37] GLUCAGON ACTION ON THE PROPERTIES OF HEPATIC MITOCHONDRIA OF NORMAL OR HYPOTHYROID RATS
    BAUDRY, M
    BRETON, L
    CLOT, JP
    ANNALES D ENDOCRINOLOGIE, 1983, 44 (03) : 173 - 173
  • [38] ACTION OF NEUTRAL RED ON SECRETION OF GLUCAGON AND GLUCOSE METABOLISM IN RAT
    OKUDA, T
    GROLLMAN, A
    ENDOCRINOLOGY, 1966, 78 (01) : 195 - &
  • [39] A glucagon receptor antagonist blocks glucagon action in cells and lowers glucose in a mouse model of diabetes
    Candelore, Mari R.
    Qureshi, Sajjad
    Jiang, Guoqiang
    Ding, Victor
    Tota, Laurie M.
    Wright, Michael J.
    Szalkowski, Deborah M.
    Yang, Xiadong
    Xu, Serena
    Dallas-Yang, Qing
    Liu, Frank
    Brady, Ed
    Saperstein, Richard
    Salituro, Gino
    Kim, Ron
    Parmee, Emma
    Zhang, Bei B.
    DIABETES, 2006, 55 : A106 - A106
  • [40] FAILURE OF BLOOD GLUCOSE LEVELS TO REFLECT HEPATIC GLYCOGENOLYSIS - EXPERIENCES WITH GLUCAGON
    SOKAL, JE
    SARCIONE, EJ
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1958, 98 (04): : 879 - 881